{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T14:41:19Z","timestamp":1702392079166},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1093\/carcin\/22.4.553","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:49:38Z","timestamp":1027723778000},"page":"553-557","source":"Crossref","is-referenced-by-count":7,"title":["Short-term dosing of \u03b1-hydroxytamoxifen results in DNA damage but does not lead to liver tumours in female Wistar\/Han rats"],"prefix":"10.1093","volume":"22","author":[{"given":"Ian N.H.","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Carthew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reginald","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Styles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,4]]},"reference":[{"key":"key\n\t\t\t\t20170725014538_R1","doi-asserted-by":"crossref","unstructured":"Baum,M. (1998) Tamoxifen\u2014The treatment of choice. Why look for alternatives? Br. J. Cancer, 78, 1\u20134.","DOI":"10.1038\/bjc.1998.753"},{"key":"key\n\t\t\t\t20170725014538_R2","doi-asserted-by":"crossref","unstructured":"Fisher,B., Costantino,J.P., Wickerham,D.L. et al. (1998) Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J. Natl Cancer Inst., 90, 1371\u20131388.","DOI":"10.1093\/jnci\/90.18.1371"},{"key":"key\n\t\t\t\t20170725014538_R3","doi-asserted-by":"crossref","unstructured":"Fisher,B., Dignam,J., Bryant,J. et al. (1996) Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J. Natl Cancer Inst., 88, 1529\u20131542.","DOI":"10.1093\/jnci\/88.21.1529"},{"key":"key\n\t\t\t\t20170725014538_R4","doi-asserted-by":"crossref","unstructured":"Carthew,P., Rich,K.J., Martin,E.A., De Matteis,F., Lim,C.K., Manson,M.M., Festing,M.F., White,I.N. and Smith,L.L. (1995) DNA damage as assessed by 32P-post-labelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formation. Carcinogenesis, 16, 1299\u20131304.","DOI":"10.1093\/carcin\/16.6.1299"},{"key":"key\n\t\t\t\t20170725014538_R5","unstructured":"Hard,G.C., Iatropoulos,M.J., Jordan,K., Radi,L., Kaltenberg,O.P., Imondi,A.R. and Williams,G.M. (1993) Major differences in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Cr1: CD(BR) rats. Cancer Res., 53, 4534\u20134541."},{"key":"key\n\t\t\t\t20170725014538_R6","unstructured":"Carthew,P., Martin,E.A., White,I.N.H., De Matteis,F., Edwards,R.E., Dorman,B.M., Heydon,R.T. and Smith,L.L. (1995) Tamoxifen induces short-term cumulative DNA damage and liver tumors in rats: Promotion by phenobarbital. Cancer Res., 55, 544\u2013547."},{"key":"key\n\t\t\t\t20170725014538_R7","doi-asserted-by":"crossref","unstructured":"White,I.N.H. (1999) The tamoxifen dilemma. Carcinogenesis, 20, 1153\u20131160.","DOI":"10.1093\/carcin\/20.7.1153"},{"key":"key\n\t\t\t\t20170725014538_R8","doi-asserted-by":"crossref","unstructured":"Potter,G.A., McCague,R. and Jarman,M. (1994) A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism. Carcinogenesis, 15, 439\u2013442.","DOI":"10.1093\/carcin\/15.3.439"},{"key":"key\n\t\t\t\t20170725014538_R9","doi-asserted-by":"crossref","unstructured":"Davis,W., Venitt,S. and Phillips,D.H. (1998) The metabolic activation of tamoxifen and \u03b1-hydroxytamoxifen to DNA-binding species in rat hepatocytes proceeds via sulphation. Carcinogenesis, 19, 861\u2013866.","DOI":"10.1093\/carcin\/19.5.861"},{"key":"key\n\t\t\t\t20170725014538_R10","unstructured":"Shibutani,S., Dasaradhi,L., Terashima,I., Banoglu,E. and Duffel,M.W. (1998) \u03b1-Hydroxytamoxifen is a substrate of hydroxysteroid (alcohol) sulfotransferase, resulting in tamoxifen DNA adducts. Cancer Res., 58, 647\u2013653."},{"key":"key\n\t\t\t\t20170725014538_R11","unstructured":"Davies,R., Oreffo,V.I.C., Martin,E.A., Festing,M., White,I.N.H., Smith,L.L. and Styles,J.A. (1997) Tamoxifen causes gene mutations in the livers of \u03bb\/lacI transgenic rats. Cancer Res., 57, 1288\u20131293."},{"key":"key\n\t\t\t\t20170725014538_R12","doi-asserted-by":"crossref","unstructured":"Fisher,B., Costantino,J.P., Redmond,C.K., Fisher,E.R., Wickerham,D.L., Cronin,W.M. and NSABP Contributors (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J. Natl Cancer Inst., 86, 527\u2013537.","DOI":"10.1093\/jnci\/86.7.527"},{"key":"key\n\t\t\t\t20170725014538_R13","unstructured":"Anonymous (1996) Tamoxifen. Some Pharmaceutical Drugs. IARC, Lyon, pp. 253\u2013365."},{"key":"key\n\t\t\t\t20170725014538_R14","unstructured":"Carmichael,P.L., Ugwumadu,A.H.N., Neven,P., Hewer,A.J., Poon,G.K. and Phillips,D.H. (1996) Lack of genotoxicity of tamoxifen in human endometrium. Cancer Res., 56, 1475\u20131479."},{"key":"key\n\t\t\t\t20170725014538_R15","unstructured":"Hemminki,K., Rajaniemi,H., Lindahl,B. and Moberger,B. (1996) Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients. Cancer Res., 56, 4374\u20134377."},{"key":"key\n\t\t\t\t20170725014538_R16","doi-asserted-by":"crossref","unstructured":"Shibutani,S., Suzuki,N., Terashima,I., Sugarman,S.M., Grollman,A.P. and Pearl,M.L. (1999) Tamoxifen\u2013DNA adducts detected in the endometrium of women treated with tamoxifen. Chem. Res. Toxicol., 12, 646\u2013653.","DOI":"10.1021\/tx990033w"},{"key":"key\n\t\t\t\t20170725014538_R17","doi-asserted-by":"crossref","unstructured":"Foster,A.B., Jarman,M. and Leung,O.T. (1985) Hydroxy derivatives of tamoxifen. J. Med. Chem., 28, 1491\u20131497","DOI":"10.1021\/jm00148a020"},{"key":"key\n\t\t\t\t20170725014538_R18","doi-asserted-by":"crossref","unstructured":"Brown,K., Brown,J.E., Martin,E.A., Smith,L.L. and White,I.N.H. (1998) Determination of DNA damage in F344 rats induced by geometric isomers of tamoxifen and analogues. Chem. Res. Toxicol., 11, 527\u2013534.","DOI":"10.1021\/tx9702289"},{"key":"key\n\t\t\t\t20170725014538_R19","unstructured":"Berry,M.N., Edwards,A.M. and Barrat,G.D. (1991) Isolated hepatocyte preparation, properties and applications. In Burdon,R.H. and van Knippenberg,P.H. (eds) Laboratory Techniques in Biochemistry and Molecular Biology. Elsevier, Amsterdam, Vol. 21, pp. 32\u201333."},{"key":"key\n\t\t\t\t20170725014538_R20","doi-asserted-by":"crossref","unstructured":"Martin,E.A., Heydon,R.T., Brown,K., Brown,J.E., Lim,C.K., White,I.N. and Smith,L.L. (1998) Evaluation of tamoxifen and \u03b1-hydroxytamoxifen 32P-post-labelled DNA adducts by the development of a novel automated on-line solid-phase extraction HPLC method. Carcinogenesis, 19, 1061\u20131069.","DOI":"10.1093\/carcin\/19.6.1061"},{"key":"key\n\t\t\t\t20170725014538_R21","doi-asserted-by":"crossref","unstructured":"Perry,B.N., McCracken,A., Furr,B.J. and MacFie,H.J. (1979) Separate roles of androgen and estrogen in the manipulation of growth and efficiency of food utilization in female rats. J. Endocrinol., 81, 35\u201348.","DOI":"10.1677\/joe.0.0810035"},{"key":"key\n\t\t\t\t20170725014538_R22","unstructured":"Greaves,P., Goonetilleke,R., Nunn,G., Topham,J. and Orton,T. (1993) Two-year carcinogenicity study of tamoxifen in Alderly Park Wistar-derived rats. Cancer Res., 53, 3919\u20133924."},{"key":"key\n\t\t\t\t20170725014538_R23","doi-asserted-by":"crossref","unstructured":"Boocock,D.J., Maggs,J.L., White,I.N.H. and Park,B.K. (1999) \u03b1-Hydroxytamoxifen, a genotoxic metabolite of tamoxifen in the rat: identification and quantification in vivo and in vitro. Carcinogenesis, 20, 153\u2013160.","DOI":"10.1093\/carcin\/20.1.153"},{"key":"key\n\t\t\t\t20170725014538_R24","unstructured":"Dahme,E. and Rattel,B. (1994) Unlike tamoxifen, droloxifene produces no hepatic tumors in the rat. Onkologie, 17, 6\u201316."},{"key":"key\n\t\t\t\t20170725014538_R25","doi-asserted-by":"crossref","unstructured":"Dragan,Y.P., Vaughan,J., Jordan,V.C. and Pitot,H.C. (1995) Comparison of the effects of tamoxifen and toremifene on liver and kidney tumor promotion in female rats. Carcinogenesis, 16, 2733\u20132741.","DOI":"10.1093\/carcin\/16.11.2733"},{"key":"key\n\t\t\t\t20170725014538_R26","doi-asserted-by":"crossref","unstructured":"White,I.N.H., De Matteis,F., Davies,A.M., Smith,L.L., Crofton-Sleigh,C., Venitt,S., Hewer,A. and Phillips,D.H. (1992) Genotoxic potential of tamoxifen and analogues in female Fischer F344\/N rats, DBA\/2 and C57Bl\/6 mice and in human MCL-5 cells. Carcinogenesis, 13, 2197\u20132203.","DOI":"10.1093\/carcin\/13.12.2197"},{"key":"key\n\t\t\t\t20170725014538_R27","doi-asserted-by":"crossref","unstructured":"Dragan,Y.P., Xu,Y., Pitot,H.C. and Xu,Y.D. (1991) Tumor promotion as a target for estrogen\/antioestrogen effects in rat hepatocarcinogenesis. Prev. Med., 20, 15\u201326.","DOI":"10.1016\/0091-7435(91)90003-M"},{"key":"key\n\t\t\t\t20170725014538_R28","unstructured":"Poon,G.K., Cui,Y.C., McCague,R., Lonning,P.E., Feng,R., Rowlands,M.G. and Jarman,M. (1995) Analysis of phase 1 and phase 11 metabolites of tamoxifen in breast cancer patients. Drug Metab. Dispos., 21, 1119\u20131194."},{"key":"key\n\t\t\t\t20170725014538_R29","doi-asserted-by":"crossref","unstructured":"Lim,C.K., Yuan,Z.X., Lamb,J.H., White,I.N., De Matteis,F. and Smith,L.L. (1994) A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes. Carcinogenesis, 15, 589\u2013593.","DOI":"10.1093\/carcin\/15.4.589"},{"key":"key\n\t\t\t\t20170725014538_R30","unstructured":"Osborne,M.R., Hewer,A., Hardcastle,I.R., Carmichael,P.L. and Phillips,D.H. (1996) Identification of the major tamoxifen\u2013deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen. Cancer Res., 56, 66\u201371."},{"key":"key\n\t\t\t\t20170725014538_R31","doi-asserted-by":"crossref","unstructured":"Rajaniemi,H., Rasanen,I., Koivisto,P., Peltonen,K. and Hemminki,K. (1999) Identification of the major tamoxifen\u2013DNA adduct in rat liver by mass spectrometry. Carcinogenesis, 20, 305\u2013309.","DOI":"10.1093\/carcin\/20.2.305"},{"key":"key\n\t\t\t\t20170725014538_R32","doi-asserted-by":"crossref","unstructured":"Lowes,D.A., Brown,K., Heydon,R.T., Martin,E.A. and Gant,T.W. (1999) Site-specific tamoxifen\u2013DNA adduct formation: Lack of correlation with mutational ability in Escherichia coli. Biochemistry, 38, 10989\u201310996.","DOI":"10.1021\/bi982704f"},{"key":"key\n\t\t\t\t20170725014538_R33","doi-asserted-by":"crossref","unstructured":"Dipple,A. (1995) DNA adducts of chemical carcinogens. Carcinogenesis, 16, 437\u2013441.","DOI":"10.1093\/carcin\/16.3.437"},{"key":"key\n\t\t\t\t20170725014538_R34","unstructured":"Hemminki,K., Dipple,A., Kadlubar,F.F., Shuker,D., Segerb\u00e4ck,D. and Bartsvh,H. (1994) DNA Adducts: Identification and Biological Significance, 125 IARC, Lyon."}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/carcin\/article\/22\/4\/553\/2529895\/Shortterm-dosing-of-\u03b1hydroxytamoxifen-results-in","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T19:57:55Z","timestamp":1512763075000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/22.4.553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2001,4]]},"published-print":{"date-parts":[[2001,4]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/22.4.553","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}